Acute graft-versus-host disease in pediatric allogeneic hematopoietic stem cell transplantation. Single-center experience during 10 yr

Maura Faraci, Ilaria Caviglia, Erika Biral, Giuseppe Morreale, Stefano Giardino, Lucia Garbarino, Elio Castagnola, Giorgio Dini, Edoardo Lanino

Research output: Contribution to journalArticle

Abstract

a-GvHD may complicate allogeneic HSCT. In this retrospective single-center study, we evaluated incidence and risk factors of a-GvHD in 197 consecutive allogeneic pediatric HSCTs applying Glucksberg and NIH a-GvHD classifications. Among 179 eligible transplants, the cumulative incidence of grade 0-I a-GvHD was 48% and grade II-IV was 52%. None of the considered variables significantly influenced the incidence of grade II-IV a-GvHD. Malignancy and myeloablation were associated with an increased risk of classic a-GvHD (p <0.01). Seventy-two percentage of children are alive, with a significant difference in OS and TRM between grade 0 and I vs. grade II and IV a-GvHD; this observation was reproduced in the non-malignant setting, while only a disparity in TRM was evidenced in children with malignancy. In our experience, the incidence of a-GvHD was similar, regardless of donor type. Myeloablation and malignant disease represented the only risk factors for classic a-GvHD. Our results highlight the need for a better prevention of this complication in the non-malignant setting.

Original languageEnglish
Pages (from-to)887-893
Number of pages7
JournalPediatric Transplantation
Volume16
Issue number8
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Pediatrics
Incidence
Neoplasms
Tissue Donors
Transplants

Keywords

  • acute graft-versus-host disease
  • children
  • refractory acute graft-versus-host disease
  • unrelated and related donor

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Acute graft-versus-host disease in pediatric allogeneic hematopoietic stem cell transplantation. Single-center experience during 10 yr. / Faraci, Maura; Caviglia, Ilaria; Biral, Erika; Morreale, Giuseppe; Giardino, Stefano; Garbarino, Lucia; Castagnola, Elio; Dini, Giorgio; Lanino, Edoardo.

In: Pediatric Transplantation, Vol. 16, No. 8, 12.2012, p. 887-893.

Research output: Contribution to journalArticle

@article{b4439a6904aa40b4a823c293e3f697f7,
title = "Acute graft-versus-host disease in pediatric allogeneic hematopoietic stem cell transplantation. Single-center experience during 10 yr",
abstract = "a-GvHD may complicate allogeneic HSCT. In this retrospective single-center study, we evaluated incidence and risk factors of a-GvHD in 197 consecutive allogeneic pediatric HSCTs applying Glucksberg and NIH a-GvHD classifications. Among 179 eligible transplants, the cumulative incidence of grade 0-I a-GvHD was 48{\%} and grade II-IV was 52{\%}. None of the considered variables significantly influenced the incidence of grade II-IV a-GvHD. Malignancy and myeloablation were associated with an increased risk of classic a-GvHD (p <0.01). Seventy-two percentage of children are alive, with a significant difference in OS and TRM between grade 0 and I vs. grade II and IV a-GvHD; this observation was reproduced in the non-malignant setting, while only a disparity in TRM was evidenced in children with malignancy. In our experience, the incidence of a-GvHD was similar, regardless of donor type. Myeloablation and malignant disease represented the only risk factors for classic a-GvHD. Our results highlight the need for a better prevention of this complication in the non-malignant setting.",
keywords = "acute graft-versus-host disease, children, refractory acute graft-versus-host disease, unrelated and related donor",
author = "Maura Faraci and Ilaria Caviglia and Erika Biral and Giuseppe Morreale and Stefano Giardino and Lucia Garbarino and Elio Castagnola and Giorgio Dini and Edoardo Lanino",
year = "2012",
month = "12",
doi = "10.1111/petr.12009",
language = "English",
volume = "16",
pages = "887--893",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Acute graft-versus-host disease in pediatric allogeneic hematopoietic stem cell transplantation. Single-center experience during 10 yr

AU - Faraci, Maura

AU - Caviglia, Ilaria

AU - Biral, Erika

AU - Morreale, Giuseppe

AU - Giardino, Stefano

AU - Garbarino, Lucia

AU - Castagnola, Elio

AU - Dini, Giorgio

AU - Lanino, Edoardo

PY - 2012/12

Y1 - 2012/12

N2 - a-GvHD may complicate allogeneic HSCT. In this retrospective single-center study, we evaluated incidence and risk factors of a-GvHD in 197 consecutive allogeneic pediatric HSCTs applying Glucksberg and NIH a-GvHD classifications. Among 179 eligible transplants, the cumulative incidence of grade 0-I a-GvHD was 48% and grade II-IV was 52%. None of the considered variables significantly influenced the incidence of grade II-IV a-GvHD. Malignancy and myeloablation were associated with an increased risk of classic a-GvHD (p <0.01). Seventy-two percentage of children are alive, with a significant difference in OS and TRM between grade 0 and I vs. grade II and IV a-GvHD; this observation was reproduced in the non-malignant setting, while only a disparity in TRM was evidenced in children with malignancy. In our experience, the incidence of a-GvHD was similar, regardless of donor type. Myeloablation and malignant disease represented the only risk factors for classic a-GvHD. Our results highlight the need for a better prevention of this complication in the non-malignant setting.

AB - a-GvHD may complicate allogeneic HSCT. In this retrospective single-center study, we evaluated incidence and risk factors of a-GvHD in 197 consecutive allogeneic pediatric HSCTs applying Glucksberg and NIH a-GvHD classifications. Among 179 eligible transplants, the cumulative incidence of grade 0-I a-GvHD was 48% and grade II-IV was 52%. None of the considered variables significantly influenced the incidence of grade II-IV a-GvHD. Malignancy and myeloablation were associated with an increased risk of classic a-GvHD (p <0.01). Seventy-two percentage of children are alive, with a significant difference in OS and TRM between grade 0 and I vs. grade II and IV a-GvHD; this observation was reproduced in the non-malignant setting, while only a disparity in TRM was evidenced in children with malignancy. In our experience, the incidence of a-GvHD was similar, regardless of donor type. Myeloablation and malignant disease represented the only risk factors for classic a-GvHD. Our results highlight the need for a better prevention of this complication in the non-malignant setting.

KW - acute graft-versus-host disease

KW - children

KW - refractory acute graft-versus-host disease

KW - unrelated and related donor

UR - http://www.scopus.com/inward/record.url?scp=84868681598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868681598&partnerID=8YFLogxK

U2 - 10.1111/petr.12009

DO - 10.1111/petr.12009

M3 - Article

C2 - 23131057

AN - SCOPUS:84868681598

VL - 16

SP - 887

EP - 893

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 8

ER -